Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Some minor resistance at .0032 at the moment.
Load and hold for the .004 break.
Recovery underway.
Get ready for the .004 break.
This will not stay down for long today.
Look for a .004 to .0043 close.
Excellent dip buy opportunity.
Expecting copper here soon.
Would like to see a .0015 close today.
This will rise.
They have the goods.
Float is still relatively small.
This is due for a massive spike.
It is way the fuck overdue for a huge spike.
Very undervalued at these prices.
300% to 400% move in a single day is in the cards.
they have the goods.
patience will get you .005 here.
just a matter of time now.
Too many fucking clowns trying to flip this for beer.
Some updates about the human trials.
This is well over .002 once we get the news.
I am hanging on to my shares.
Next week should be good for this stock.
Hi Gail.
I grabbed a few more also.
Hoping for a big run here.
You can expect $2 here soon.
This will skyrocket.
This should be able to break .002 tomorrow.
.0018s starting to get hit.
Letβs go for .002 today.
Something brewing obviously.
This is ready for the next leg which should take it to .003.
They are likely to get bought out.
Over 100 patents.
Key drugs in development.
This is massively undervalued.
get after it ASAP.
attack the dip.
huge opportunity here to score quick 300% gains.
this will blow up this week.
$3 to $4 is not out of the question.
Overall response rate of 90% in cohort with durable responses observed; one patient remains in complete remission at 31 months
All patients were heavily pretreated/refractory to BTK inhibitors, and only one patient has started new anti-WM treatment after MB-106
Outpatient administration was allowed and found to be feasible
Currently no FDA-approved CAR-T treatments for WM
Data presented at the European Hematology Association 2024 Hybrid Congress
WORCESTER, Mass., June 17, 2024 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (βMustangβ or the βCompanyβ) (Nasdaq: MBIO), a clinical-stage biopharmaceutical company focused on translating todayβs medical breakthroughs in cell therapies into potential cures for difficult-to-treat cancers, today announced that updated data from the ongoing Phase 1/2 clinical trial of MB-106, a CD20-targeted, autologous CAR T-cell therapy, show a favorable safety and efficacy profile in patients with Waldenstrom macroglobulinemia (βWMβ), a rare form of blood cancer. MB-106 is being developed in a collaboration between Mustang and Fred Hutch Cancer Center (βFred Hutchβ) to treat patients with relapsed or refractory B-cell non-Hodgkin lymphomas (βB-NHLsβ) and chronic lymphocytic leukemia (βCLLβ).
expecting this to skyrocket again on thursday morning.
Excellent re-entry point.
This will blow by $2 this week.
.0012 to .0013 is the support.
It will lift off from here.
$PPCB
massively undervalued biotech with key/vital drugs in development.
this will go to silver.
it has found support at these levels.
so the downside risk is minimal at best now.
translation: she is setting up to rise.
this is an excellent entry point.
i am freeing up some more cash tomorrow to load up some more.
i know this will rocket to copper at some point.
Little bit of patience is all that is needed here.
We all know they have the big catalysts.
I am holding this stock for copper.
Next leg in progress.
Next station:
.003 break coming this week.
Been adding more here for 2 weeks now.
This is setting up to skyrocket.
$RONN and $GTVH:
massively undervalued.
massively oversold.
both offer staggering potential.
i think tomorrow is the big day for both of these stocks.
Trader59 is a paid basher of stocks.
This is how you address the issues and update shareholders. It is highly appreciated, keep up the good work! Canβt wait to hear more projects and rapid growth the company is achieving at a short period of time $ronn https://t.co/jpW28AZdP8
— Be Free |Dividend Girl| (@DividendETFGirl) May 30, 2024
should bounce back strong tomorrow.
$RONN YES @buffalofireside PLEASE CONSIDER CONNECTING WITH @leepharma FOR AN INTERVIEW TODAY ππ» https://t.co/EH77QccUig
— DA87 (@DA87ONE) May 30, 2024
what we have accomplished below π. Just one deal has the potential of $350,000,000 that we disclosed and we have many others we are working on so we hope our shareholders stay patient with us as we grow and continue to work our ass off.
— RONN inc (Formerly $LPHM) (@leepharma) May 30, 2024
(Cont)
.012 to .013.